LFCR 8-K 2026-10-20

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) 8-K dated 2026-10-20 — accession 0001005286-26-000040. This URL is the filing, not the LFCR hub.

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.

LIFECORE BIOMEDICAL, INC. \DE\ filed a 8-K on 2026-10-20. Accession 0001005286-26-000040.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LFCR revenue for 2026-06-30 was $34.2M. Net income was -$6.2M. Revenue was up 47.3% from 2026-03-31 to 2026-06-30. LFCR currently screens at market cap $207.1M.

Not investment advice. The LFCR SEC hub lists recent forms. The stock page is the research view.